Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia
NCT ID: NCT03415035
Last Updated: 2025-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
269 participants
OBSERVATIONAL
2018-03-09
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
NCT03342144
A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)
NCT04198415
A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice
NCT03659669
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
NCT04895436
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
NCT03319901
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Chronic Lymphocytic Leukemia (CLL)
Patients with diagnosed CLL and eligible to venetoclax as per label
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants for whom the physician has decided to initiate CLL treatment with venetoclax.
* Participants the physician believes he can personally follow over all the study period.
* Participants who have been informed verbally and in writing about this study, and who do not object to their data being electronically processed or subjected to data quality control.
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Cannes - les Broussailles /ID# 201108
Cannes, Alpes-Maritimes, France
CH CARCASSONNE - Antoine Gayraud /ID# 202530
Carcassonne, Aude, France
CHU Clermont-Ferrand /ID# 170736
Clermont, Auvergne-Rhône-Alpes, France
Clinique Pole santé République /ID# 204658
Clermont-Ferrand, Auvergne, France
CH de la Haute-Saône - Vesoul /ID# 205150
Vesoul, Bourgogne-Franche-Comté, France
CHU de RENNES /ID# 169944
Rennes, Brittany Region, France
CHU de Besancon - Jean Minjoz /ID# 170721
Besançon, Doubs, France
Centre Hospitalier de Cornouaille /ID# 169937
Quimper, Finistere, France
CHU Limoges - Dupuytren 1 /ID# 200193
Limoges, Franche-Comte, France
Institut Bergonie /ID# 170746
Bordeaux, Gironde, France
CH Roubaix - Hopital Victor Provo /ID# 170909
Roubaix, Hauts-de-France, France
CHU Montpellier - Hopital Saint Eloi /ID# 200192
Montpellier, Herault, France
CH de Saint-Malo - Hôpital Broussais /ID# 169935
St-Malo, Ille-et-Vilaine, France
CHRU Tours - Hopital Bretonneau /ID# 169469
Tours, Indre-et-Loire, France
CHU Grenoble - Hopital Michallon /ID# 170741
La Tronche, Isere, France
CHU Reims - Hôpital Robert Debre /ID# 170917
Reims, Marne, France
CHRU Nancy - Hopitaux de Brabois /ID# 170855
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
CH Bretagne Atlantique /ID# 200191
Vannes, Morbihan, France
CHR Metz-Thionville - Hopital Bel-Air /ID# 170722
Thionville, Moselle, France
IUCT Oncopole /ID# 170749
Toulouse, Occitanie, France
AP-HP - Hopital Bicetre /ID# 170747
Le Kremlin-Bicêtre, Paris, France
Hopital de la Conception /ID# 201981
Marseille, Provence-Alpes-Côte d'Azur Region, France
Centre Hospitalier de la Cote Basque /ID# 170735
Bayonne, Pyrenees-Atlantiques, France
Centre Leon Berard /ID# 170018
Lyon, Rhone, France
Clinique Victor Hugo /ID# 169973
Le Mans, Sarthe, France
Centre Hospitalier du Mans /ID# 169451
Le Mans, Sarthe, France
Hopital de Melun /ID# 202569
Melun, Seine-et-Marne, France
Centre Henri Becquerel /ID# 169948
Rouen, Seine-Maritime, France
CHU Amiens-Picardie Site Sud /ID# 170724
Amiens, Somme, France
Institut Gustave Roussy /ID# 202436
Villejuif, Val-de-Marne, France
CHU Poitiers - La miletrie /ID# 169470
Poitiers, Vienne, France
CHI POISSY - Saint-Germain-en-Laye /ID# 169966
Saint-Germain-en-Laye, Yvelines, France
Ch Agen /Id# 170742
Agen, , France
CH Victor Dupouy /ID# 169946
Argenteuil, , France
Ch Blois /Id# 170727
Blois, , France
CHRU de Brest - Hopital Morvan /ID# 169457
Brest, , France
CHU de CAEN - Hopital de la Cote de Nacre /ID# 169941
Caen, , France
Hopital Prive Sevigne /Id# 170718
Cesson-Sévigné, , France
Medipole de Savoie /ID# 169454
Challes-les-Eaux, , France
CH William Morey /ID# 169939
Chalon-sur-Saône, , France
Centre Hospitalier de CHOLET /ID# 171215
Cholet, , France
Hopital d'Instruction des Armées PERCY /ID# 170740
Clamart, , France
Centre Joseph BELOT /ID# 170853
Désertines, , France
CH Annecy Genevois - Site Annecy /ID# 200826
Epagny Metz Tessy, , France
Centre Hospitalier de Versailles André Mignot /ID# 169950
Le Chesnay, , France
CH Libourne - Hopital Robert Boulin /ID# 170739
Libourne, , France
Hopital Saint Vincent de Paul /ID# 169956
Lille, , France
Clinique de la Sauvegarde /ID# 169904
Lyon, , France
CH Princesse Grace /ID# 200196
Monaco, , France
CH Mont de MARSAN /ID# 169955
Mont-de-Marsan, , France
Ch Mulhouse /Id# 170726
Mulhouse, , France
Polyclinique le LANGUEDOC /ID# 169925
Narbonne, , France
Centre Hospitalier Régional d'Orléans - Hôpital de la Source /ID# 169453
Orléans, , France
Hôpital Saint-Louis /ID# 170856
Paris, , France
Centre Hospitalier de Perpignan /ID# 170743
Perpignan, , France
CH Périgueux /ID# 169458
Périgueux, , France
CH Saint-Brieuc /ID# 171076
Saint-Brieuc, , France
Hopital Nord Franche Comté /ID# 170744
Trévenans, , France
Hopital Avicenne - APHP /ID# 169940
Bobigny, Île-de-France Region, France
Hopital Pitie Salpetriere /ID# 169974
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P16-913
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.